Schistosomiasis
Also known as: Bilharzia, Schistosomal infection, Intestinal schistosomiasis, Urogenital schistosomiasis, Schistosomiasis japonica
Schistosomiasis is a parasitic infection acquired through contact with contaminated freshwater. Clinical manifestations vary depending on species and disease stage, involving the bowel, urinary tract, or liver, with a risk of significant chronic complications. Medical assessment, species-appropriate investigation, and antiparasitic pharmacotherapy remain essential; symptom resolution does not equate to parasite clearance. Within Traditional Chinese Medicine, practitioners may provide an adjunctive framework for persistent digestive symptoms, fatigue, or discomfort post-medical evaluation, provided conventional treatment is not delayed. Cited evidence contains no clinical data validating acupuncture or herbal medicine for schistosomiasis. Record [3] addresses local infection burden and prevention gaps rather than therapeutic efficacy. Safety recommendations are general clinical precautions and lack specific validation evidence within the cited material.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Abstain from swimming, wading, or bathing in untreated freshwater within endemic regions and consult local public health authorities regarding unavoidable occupational exposure.
- •Utilise potable or treated water sources for personal hygiene and adhere to local sanitation and exposure-prevention protocols.
- •Adhere to all scheduled pharmacological treatments and follow-up consultations; ensure clinicians are provided with a comprehensive travel and freshwater-exposure history.
- •Implement gradual activity pacing during convalescence, maintain a regular nutritional intake, and strictly avoid alcohol consumption if hepatic involvement is suspected or confirmed.
Cautions & Contraindications
- •Do not substitute acupuncture or herbs for diagnostic testing, prescribed antiparasitic treatment or complication management. The supplied records establish no adjunctive treatment efficacy; [3] concerns infection burden and prevention only.[]
- •Avoid abdominal needling over an enlarged liver or spleen, ascites, distended veins, unexplained masses or painful areas awaiting investigation. Defer needling with active bleeding or clinically significant coagulopathy pending medical clearance. These are general safety precautions, not findings tested in [3].[]
- •Do not start a multi-herb formula during antiparasitic treatment without medicine reconciliation and assessment of liver and kidney function where indicated. Pregnancy, breastfeeding, childhood and advanced hepatic disease require individual specialist review. Record [3] does not establish herb–drug compatibility or population-specific safety.[]
When to reassess or seek care again
Confirm that medical investigation and antiparasitic management are arranged before adjunctive care. Review any stable adjunctive symptom trial within 1–2 weeks, recording fatigue on a 0–10 scale, stool frequency and consistency, appetite, discomfort and adverse effects. Stop and refer for worsening symptoms, bleeding, fever, jaundice or abdominal swelling; refer for persistent symptoms without meaningful improvement by 2–4 weeks. Parasite clearance and organ complications require the treating clinician's testing schedule, not tongue, pulse or symptom assessment alone.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Journal of medical biography · 2026
- Endocrine research · 2026
- Transactions of the Royal Society of Tropical Medicine and Hygiene · 2025
- Breast cancer research and treatment · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
